Evidence map›Paper›PMID 39918337›Full record

ArticleCancer discovery2025

Stromal KITL/SCF Maintains Pancreas Tissue Homeostasis and Restrains Tumor Progression.

Maria Kathrina Oñate, Chet Oon, Sohinee Bhattacharyya, Vivien Low, Canping Chen, Xiaofan Zhao, Frank Arnold, Ziqiao Yan, Sneha Pramod, Yan Hang and 5 more

Abstract read
In one paragraph

Article in Cancer discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Maria Kathrina OñateCancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0003-3495-6038
Chet OonCancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0002-1494-6628
Sohinee BhattacharyyaCancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0001-6180-8415
Vivien LowCancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0002-8561-011X
Canping ChenDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon.ORCID 0000-0003-4021-8592
Xiaofan ZhaoDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon.ORCID 0000-0002-7286-7303
Frank ArnoldCancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0003-0025-3668
Ziqiao YanDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, California.ORCID 0009-0001-6195-0849
Sneha PramodCancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0002-9282-3332
Yan HangDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, California.ORCID 0000-0002-5166-2480
Yu-Jui HoCancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0002-7540-024X
Scott W LoweCancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0002-5284-9650
Seung K KimDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, California.ORCID 0000-0001-6135-7810
Zheng XiaDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon.ORCID 0000-0003-3364-8324
Mara H ShermanCancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0001-7826-3888

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Understanding the origins of rapid recurrence of pancreatic cancer after resectionP30CA069533 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Luiz Eduardo Bertassoni · 1997 to 2026
$60.5M
Project 3: Impact of tumor genetics on PDAC immunobiology and responses to macrophage-targeted immunotherapyP01CA244114 · NCI · STANFORD UNIVERSITY · PI KIM, SEUNG K · 2021 to 2025
$10.0M
Identifying and Targeting Metabolic Dependencies in the Pancreatic Tumor MicroenvironmentR01CA229580 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Mara H. Sherman · 2018 to 2026
$3.8M
Mechanisms of p53 Engagement and Action at the Benign-to-Malignant Transition in Sporadic TumorigenesisR01CA283378 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI SCOTT W. LOWE, Dana Pe'er · 2023 to 2026
$2.9M
Origins and functions of pancreatic cancer-associated fibroblastsR01CA250917 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Mara H. Sherman · 2021 to 2026
$2.3M
Characterizing phenotype-associated subpopulations from single-cell sequencing dataR01GM147365 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Zheng Xia · 2023 to 2026
$1.2M
Object Storage for Secure Data SharingS10OD025082 · OD · STANFORD UNIVERSITY · PI DATTA, SOMALEE · 2018 to 2018
$593k
Howard Hughes Medical Institute (HHMI)Lustgarten Foundation (Lustgarten)NCI NIH HHS P01 CA244114NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA069533NCI NIH HHS R01 CA229580NCI NIH HHS R01 CA250917NCI NIH HHS R01 CA283378NIGMS NIH HHS R01 GM147365NIH HHS S10 OD025082ODCDC CDC HHS S10 OD025082
6 · The paper itself

Abstract

abstractComponents of normal tissue architecture serve as barriers to tumor progression. Inflammatory and wound-healing programs are requisite features of solid tumorigenesis, wherein alterations to immune and nonimmune stromal elements enable loss of homeostasis during tumor onset. The precise mechanisms by which normal stromal cell states limit tissue plasticity and tumorigenesis, and which are lost during tumor progression, remain largely unknown. In this study, we show that healthy pancreatic mesenchyme expresses the paracrine signaling molecule KITL, also known as stem cell factor, and identify the loss of stromal KITL during tumorigenesis as tumor promoting. Genetic inhibition of mesenchymal KITL in the contexts of health, injury, and cancer together indicates a role for KITL signaling in the maintenance of pancreas tissue architecture, such that the loss of the stromal KITL pool increased tumor growth and reduced survival of tumor-bearing mice. Together, these findings implicate the loss of mesenchymal KITL as a mechanism for establishing a tumor-permissive microenvironment. SIGNIFICANCE: By analyzing transcriptional programs in healthy and tumor-associated pancreatic mesenchyme, we find that a subpopulation of mesenchymal cells in healthy pancreas tissue expresses the paracrine signaling factor KITL. The loss of mesenchymal KITL is an accompanying and permissive feature of pancreas tumor evolution, with potential implications for cancer interception. See related article by Dolskii and Cukierman, p. 872.

Indexed as

PancreasPancreatic NeoplasmsAnimalsDisease ProgressionHomeostasisHumansMesenchymal Stem CellsMice

Identifiers

PMID39918337
PMCPMC12046321

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.